BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 19400885)

  • 1. Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin.
    Joshi SS; Boone SL; Alam M; Yoo S; White L; Rademaker A; Helenowski I; West DP; Kundu RV
    Dermatol Surg; 2009 Apr; 35(4):638-44; discussion 644. PubMed ID: 19400885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of electrodesiccation and potassium-titanyl-phosphate laser for treatment of dermatosis papulosa nigra.
    Kundu RV; Joshi SS; Suh KY; Boone SL; Huggins RH; Alam M; White L; Rademaker AW; West DP; Yoo S
    Dermatol Surg; 2009 Jul; 35(7):1079-83. PubMed ID: 19469798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of salicylic acid peeling in comparison with topical tretinoin in the treatment of postinflammatory hyperpigmentation.
    Mohamed Ali BM; Gheida SF; El Mahdy NA; Sadek SN
    J Cosmet Dermatol; 2017 Mar; 16(1):52-60. PubMed ID: 27976510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation.
    Downie J; Schneider K; Goberdhan L; Makino ET; Mehta RC
    J Drugs Dermatol; 2017 Apr; 16(4):301-306. PubMed ID: 28403262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Jessner's solution peel in comparison with salicylic acid 30% peel in the management of patients with acne vulgaris and postacne hyperpigmentation with skin of color: a randomized, double-blinded, split-face, controlled trial.
    How KN; Lim PY; Wan Ahmad Kammal WSL; Shamsudin N
    Int J Dermatol; 2020 Jul; 59(7):804-812. PubMed ID: 32447767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial comparing a chemical peel containing a lipophilic hydroxy acid derivative of salicylic acid with a salicylic acid peel in subjects with comedonal acne.
    Levesque A; Hamzavi I; Seite S; Rougier A; Bissonnette R
    J Cosmet Dermatol; 2011 Sep; 10(3):174-8. PubMed ID: 21896127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postinflammatory hyperpigmentation in patients with skin of color.
    Shokeen D
    Cutis; 2016 Jan; 97(1):E9-E11. PubMed ID: 26919365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women.
    Kodali S; Guevara IL; Carrigan CR; Daulat S; Blanco G; Boker A; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2010 Dec; 63(6):1030-5. PubMed ID: 20889235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris.
    Kessler E; Flanagan K; Chia C; Rogers C; Glaser DA
    Dermatol Surg; 2008 Jan; 34(1):45-50; discussion 51. PubMed ID: 18053051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Postinflammatory Hyperpigmentation With a Combination of Glycolic Acid Peels and a Topical Regimen in Dark-Skinned Patients: A Comparative Study.
    Sarkar R; Parmar NV; Kapoor S
    Dermatol Surg; 2017 Apr; 43(4):566-573. PubMed ID: 28114204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical tolerance and efficacy of capryloyl salicylic acid peel compared to a glycolic acid peel in subjects with fine lines/wrinkles and hyperpigmented skin.
    Oresajo C; Yatskayer M; Hansenne I
    J Cosmet Dermatol; 2008 Dec; 7(4):259-62. PubMed ID: 19146601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups.
    Grimes PE
    Dermatol Surg; 1999 Jan; 25(1):18-22. PubMed ID: 9935087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma.
    Sarkar R; Garg V; Bansal S; Sethi S; Gupta C
    Dermatol Surg; 2016 Mar; 42(3):384-91. PubMed ID: 26859648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichloroacetic Acid Versus Salicylic Acid in the Treatment of Acne Vulgaris in Dark-Skinned Patients.
    Abdel Meguid AM; Elaziz Ahmed Attallah DA; Omar H
    Dermatol Surg; 2015 Dec; 41(12):1398-404. PubMed ID: 26551771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone.
    Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2013 Jan; 12(1):52-8. PubMed ID: 23377328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels.
    Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA
    Dermatol Surg; 2006 Dec; 32(12):1429-36. PubMed ID: 17199649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study.
    Burns RL; Prevost-Blank PL; Lawry MA; Lawry TB; Faria DT; Fivenson DP
    Dermatol Surg; 1997 Mar; 23(3):171-4; discussion 175. PubMed ID: 9145958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salicylic acid peels versus Jessner's solution for acne vulgaris: a comparative study.
    Bae BG; Park CO; Shin H; Lee SH; Lee YS; Lee SJ; Chung KY; Lee KH; Lee JH
    Dermatol Surg; 2013 Feb; 39(2):248-53. PubMed ID: 23121256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris.
    Tiplica GS; Salavastru CM
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):905-12. PubMed ID: 19470062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.